AnodyneWiki

Warfarin

Warfarin
Warfarin
Salts
[]
Potassium warfarin
Potassium warfarin
Sodium warfarin
Sodium warfarin
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass308.30 g/mol [1]
AppearanceCrystals from alcohol [1]
OdorOdorless [1]
TasteTasteless [1]
DensityRelative density (water = 1): 1.4 [1]
Melting point322 °F (EPA, 1998) [1]
Boiling pointDecomposes (NIOSH, 2024) [1]
DecompositionWhen heated to decomposition it emits acrid smoke & fumes. [1]
Solubility0.002 % (NIOSH, 2024) [1]
Predicted LogP2.7 [1]
Structural Identifiers
[]
Molecular formulaC19H16O4
IUPAC name4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one
SMILESCC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O
InChIInChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3
InChIKeyPJVWKTKQMONHTI-UHFFFAOYSA-N
CAS number81-81-2
UNII5Q7ZVV76EI
PubChem CID54678486
Pharmacokinetics[]
Elimination half-life7 days (active half-life is 20-60 hours)
MetabolismLiver: CYP2C9, 2C19, 2C8, 2C18, 1A2 and 3A4
ExcretionKidney (92%)
Routes of administrationBy mouth, intravenous
Toxicity
[]
Mouse:
- oral: 374 mg/kg /Warfarin
- iv: 160 mg/kg /Warfarin
- Oral: 374 mg/kg
Rat:
- iv: 25 mg/kg /Warfarin
- oral: 8700 μg/kg /Warfarin
 [1]

Warfarin (also known as Coumafene, Zoocoumarin, Brumolin, Coumafen, Coumefene, Warfarine, Dethmor, Kumader, Kumadu or Vampirinip II) is a substance of the phenol class.

Chemistry

Salts []

Warfarin is typically found in the form of its potassium and sodium salts.

 []

Warfarin is a racemic mixture of the (optical activity ( + / - )).

Warfarin matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Warfarin is a [vitamin K] antagonist which acts to inhibit the production of vitamin K by vitamin K epoxide reductase. The reduced form of vitamin K, vitamin KH<sub>2</sub> is a cofactor used in the γ-carboxylation of coagulation factors VII, IX, X, and thrombin. Carboxylation induces a conformational change allowing the factors to bind Ca<sup>2+</sup> and to phospholipid surfaces. Uncarboxylated factors VII, IX, X, and thrombin are biologically inactive and therefore serve to interrupt the coagulation cascade. The endogenous anticoagulation proteins C and S also require γ-carboxylation to function. This is particularly true in the case of thrombin which must be activated in order to form a thrombus. vitamin KH<sub>2</sub> is converted to vitamin K epoxide as part of the γ-carboxylation reaction catalyzed by γ-glutamyl carboxylase. Vitamin K epoxide is then converted to vitamin K<sub>1</sub> by vitamin K epoxide reductase then back to vitamin KH<sub>2</sub> by vitamin K reductase. Warfarin binds to vitamin K epoxide reductase complex subunit 1 and irreversibly inhibits the enzyme thereby stopping the recycling of vitamin K by preventing the conversion of vitamin K epoxide to vitamin K<sub>1</sub>. This process creates a hypercoagulable state for a short time as proteins C and S degrade first with half lives of 8 and 24 hours, with the exception of factor VII which has a half life of 6 hours. Factors IX, X, and finally thrombin degrade later with half lives of 24, 36, and 50 hours resulting in a dominant anticoagulation effect. In order to reverse this anticoagulation vitamin K must be supplied, either exogenously or by removal of the vitamin K epoxide reductase inhibition, and time allowed for new coagulation factors to be synthesized. It takes approximately 2 days for new coagulation factors to be synthesized in the liver. Vitamin K<sub>2</sub>, functionally identical to vitamin K<sub>1</sub>, is synthesized by gut bacteria leading to interactions with antibiotics as elimination of these bacteria can reduce vitamin K<sub>2</sub supply and result in a greater anticoagulation effect. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction165 (2 contraindicated)
shared target14
shared target4

Medical side effects []

85 side effects listed on drug labels in (warfarin).

  • Abdominal pain
  • Gastrointestinal pain
  • Alopecia
  • Anaphylactic shock
  • Anaemia
  • Angina pectoris
  • Asthenia
  • Fatigue
  • Chest pain
  • Temperature intolerance
  • Coma
  • Infection
  • Dermatitis
  • Rash
  • Diarrhoea
  • Dizziness
  • Syncope
  • Dysgeusia
  • Dyspnoea
  • Ecchymosis
  • Oedema
  • Epistaxis
  • Body temperature increased
  • Flatulence
  • Abdominal bloating
  • Gastrointestinal disorder
  • Gastrointestinal haemorrhage
  • Headache
  • Haematemesis
  • Subdural haematoma
  • Haematuria
  • Haemorrhage
  • Haemoglobin
  • Haemothorax
  • Hepatitis
  • Hypersensitivity
  • Hypotension
  • Immune system disorder
  • Infarction
  • Jaundice
  • Lethargy
  • Mediastinal disorder
  • Melaena
  • Muscle spasms
  • Nausea
  • Neoplasm
  • Nervous system disorder
  • Pain
  • Pallor
  • Pancreatitis
  • Paraesthesia
  • Priapism
  • Pruritus
  • Shock
  • Skin disorder
  • Swelling
  • Loss of consciousness
  • Ulcer
  • Urethral disorder
  • Urinary tract disorder
  • Urticaria
  • Angiopathy
  • Vasculitis
  • Vomiting
  • Chills
  • Hepatic function abnormal
  • Hepatitis cholestatic
  • Skin necrosis
  • Skin exfoliation
  • Liver injury
  • Traumatic liver injury
  • Haemoglobin decreased
  • Malaise
  • Discomfort
  • Feeling abnormal
  • Ill-defined disorder
  • Dermatitis bullous
  • Hepatic enzyme increased
  • Fat embolism
  • Blue toe syndrome
  • Rectal haemorrhage
  • Hepatobiliary disease
  • Paralysis
  • Abdominal distension
  • Cerebral haemorrhage

Indications

  • Atrial fibrillation
  • Cardiac failure congestive
  • Cerebral artery embolism
  • Cerebrovascular accident
  • Clotting
  • Embolism
  • Genetic polymorphism
  • Haemorrhage
  • Hepatic function abnormal
  • Hepatic impairment
  • Increased anticoagulant effect
  • Myocardial infarction
  • Pulmonary embolism
  • Renal failure
  • Renal impairment
  • Thromboembolic event
  • Thromboembolism
  • Thrombophlebitis
  • Thrombosis
  • Venous thrombosis

 []

  • Australia: Warfarin is a Schedule 4.
  • Canada: Warfarin is Prescription only.[3][4]
  • United Kingdom: Warfarin is Prescription only.[5]
  • United States: Warfarin is Prescription only.[6]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 54678486, Warfarin. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/54678486
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Warfarin. UNII: 5Q7ZVV76EI. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/5Q7ZVV76EI
  3. Product information. Health Canada. 3 August 2000. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=163
  4. Product information. Health Canada. 30 June 2020. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12818
  5. Summary of Product Characteristics (SmPC). (emc). 7 November 2023. https://www.medicines.org.uk/emc/product/2803/smpc
  6. Coumadin- warfarin sodium tablet. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ebcb71e-9a7e-4969-abb9-7c7d3e3aae3c

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 18:59:40
drugspromissing (no DrugsPRO reagent data)2026-11-20 18:59:36
erowidmissing (no Erowid substance of that name)2026-11-20 18:59:36
gsrsok2026-11-20 18:59:38
hmdbmissing (hmdb.ca refused automated access to HMDB0001935)2026-11-20 18:59:36
keggok2026-11-20 18:59:40
pubchemok2026-11-20 18:59:35
redditmissing (no r/tripreports posts mention it)2026-11-20 18:59:36
siderok2026-11-20 18:59:36
structureok2026-11-20 18:59:36
wikipediaok2026-11-20 18:59:36